aim
sarsassoci
coronaviru
sarscov
confirm
pathogen
sever
acut
respiratoabstract
ry
syndrom
sar
aim
studi
construct
sensit
specif
realtim
quantit
fluoresc
qf
revers
transcriptas
rt
pcr
method
detect
sarscov
rna
method
store
blood
specimen
patient
confirm
sar
use
along
blood
sampl
two
set
control
healthi
volunt
contact
sar
patient
healthi
doctor
nurs
contact
sar
patient
without
symptom
sar
two
pair
primer
synthes
shanghai
sangon
compani
accord
sarscov
strain
sequenc
pair
primer
design
compar
pair
primer
publish
result
use
serial
dilut
sarscov
blood
sampl
sar
patient
specimen
test
use
dilut
sarscov
clinic
sampl
test
posit
assay
comparison
use
dilut
sarscov
sampl
test
posit
use
primer
qfrtpcr
assay
linear
amplif
copi
copi
control
rna
per
rtpcr
least
copi
sometim
even
copi
target
rna
test
posit
assay
conclus
primer
develop
suffici
sensit
specif
diagnos
symptomat
sarscov
infect
monitor
viru
load
begin
novemb
epidem
sever
character
fever
nonproduct
cough
dyspnea
chest
pain
lung
infiltr
fibrosi
decreas
lymphocyt
atyp
pneumonia
design
sever
acut
respiratori
syndrom
count
similar
symptom
acut
febril
ill
sar
world
health
organ
first
obe
influenza
other
atyp
pneumonia
serv
chines
provinc
guangdong
novemb
infect
peopl
caus
death
counit
difficult
differenti
sar
tri
sarsassoci
coronaviru
cov
confirm
acut
febril
ill
clinic
diagnosi
therefor
laboratori
pathogen
absenc
effect
drug
vaccin
method
sar
diagnosi
import
laboagainst
sar
control
diseas
reli
rapid
identifiratori
test
sar
primarili
pcrbase
cation
case
appropri
manag
individu
viru
isol
detect
viral
rna
patient
secretionsexcret
come
close
contact
howev
diseas
ii
antibodybas
detect
immun
respons
titer
antibodi
blood
howev
method
dict
final
rna
concentr
hamper
need
viru
isol
take
place
biosafeti
level
condit
serolog
test
may
becom
copiesml
dilut
perform
suffici
posit
one
week
onset
symptom
number
aliquot
dilut
store
develop
rapid
earli
diagnost
method
high
primer
prioriti
monitor
control
diseas
research
sever
countri
work
toward
develop
fast
two
pair
primer
synthes
shanghai
sangon
accur
laboratori
diagnost
test
sarscov
compani
shanghai
china
accord
sarscov
strain
report
describ
sensit
specif
quantit
fluoresc
sequenc
tabl
qf
rtpcr
assay
detect
sarscov
rna
strain
downstream
promot
linear
confluent
layer
vero
cell
infect
psti
purifi
pcr
purif
kit
shanghai
biotech
strain
sarscov
hour
cell
harvest
shanghai
china
transcrib
rna
polymeras
use
inactiv
hour
inactiv
cell
cultur
express
larg
scale
rna
product
system
dilut
dilut
healthi
blood
promega
madison
wi
usa
templat
dna
degrad
rnasefre
dnase
rna
transcript
purifi
twice
rneasi
kit
qiagen
gmbh
hilden
germani
rna
quantifi
spectrophotometr
dilut
divid
aliquot
store
use
store
blood
specimen
patient
taken
dilut
sarscov
transcript
week
onset
diseas
fulfil
clinic
use
gener
standard
curv
singlecopi
assay
case
definit
sar
diagnosi
subsequ
confirm
seroconvers
posit
sarscov
isol
rna
extract
revers
transcript
control
blood
sampl
collect
two
addit
group
healthi
volunt
contact
sar
patient
total
rna
extract
use
qiaamp
rna
blood
mini
healthi
doctor
nurs
contact
histori
kit
qiagen
gmbh
hilden
germani
accord
hospit
without
symptom
sar
day
manufactur
instruct
blood
sampl
sampl
sampl
whole
blood
sampl
collect
vacuum
mix
buffer
el
lyse
red
cell
cencontain
edta
transfer
laboratori
trifug
minut
supernat
rna
extract
immedi
remov
deposit
collect
rna
extract
sampl
studi
volum
directli
standard
sarscov
panel
use
rna
extract
rna
redissolv
sarscov
virion
known
concentr
sarscov
qualidiethyl
pirocarbon
depc
treat
water
contain
dnase
ty
assur
laboratori
nation
institut
control
incub
minut
follow
inactiv
pharmaceut
biolog
product
beij
china
minut
rna
use
immedi
store
serial
dilut
sarscovseroneg
human
plasma
pre
step
perform
biosafeti
level
laboratori
synthesi
cdna
undertaken
revers
transcript
rna
extract
minut
follow
incub
minut
solut
contain
mmoll
trishcl
quenc
shown
ident
publish
sarscov
sequenc
determin
specif
control
sampl
determin
dynam
rang
serial
dilut
standard
ed
perform
denatur
sarscov
rna
contain
target
sequenc
test
minut
minut
wide
linear
rang
begin
copi
extend
copi
control
plasmid
establish
least
result
copi
sometim
even
copi
target
rna
test
posit
assay
figur
demonstr
accuraci
qfrtpcr
assay
qfrtto
compar
sensit
two
pair
primer
serial
pcr
product
serial
dilut
standard
sarscov
rna
dilut
sarscov
posit
clinic
specimen
contain
target
sequenc
also
detect
pcrethidium
bromid
eb
stain
method
qfrtpcr
copi
ever
primer
publish
sarscov
locat
faint
band
figur
open
read
frame
sarscov
sens
rna
viru
target
fragment
discuss
near
termin
viru
genom
design
pair
primer
expect
amplifi
studi
analyz
blood
sampl
patient
bp
length
cover
region
viru
confirm
sar
use
seroconvers
basi
publish
sequenc
sarscov
posit
sarscov
isol
infect
vero
cell
mani
data
pair
primer
publish
compar
show
bloodborn
sarscov
load
may
quit
low
even
primer
confirm
sensit
primer
serial
dilut
viremia
occur
altern
patient
may
sarscov
clinic
sampl
use
compar
even
develop
viremia
virus
propag
primer
primer
appear
greater
sensit
epitheli
tissu
lung
therefor
studi
pcr
product
sampl
test
neg
primer
assay
select
sampl
posit
viru
isol
posit
primer
assay
sequenc
match
rtpcrbase
test
use
primer
pair
publish
correctli
sarscov
determin
specif
sami
reliabl
identif
method
avail
public
sensit
specif
method
howpl
close
contact
healthi
medic
personnel
fig
sensit
dynam
rang
quantit
fluoresc
qf
revers
transcriptas
rt
pcr
detect
sever
acut
respiratori
syndrom
sar
associ
coronaviru
cov
rna
serial
dilut
standard
sarscov
rna
contain
target
sequenc
test
wide
linear
rang
begin
copi
extend
copi
control
plasmid
per
qfrtpcr
establish
least
copi
sometim
even
copi
target
rna
test
posit
assay
intercept
magnitud
fluoresc
signal
pcr
baselin
subtract
curv
fit
rel
fluoresc
unit
cf
rfu
horizont
threshold
line
repres
threshold
cycl
valu
given
sampl
